Submissions

      Editorial Manager Login

or click here to log in: EJMINT on Editorial Manager

Back to top

Author Information

EJMINT publishes original articles in the field of minimally invasive neurological therapies and related educational, socioeconomic and medico-legal issues. The Editors determine EJMINT content. English is the official language of EJMINT.

EJMINT will consider the following types of articles for publication: Original Research, Technical Notes, Reviews, Editorials and Letters to the Editor. All articles will be published as Open Access.

Submitted manuscripts must not contain previously published material or material under consideration for publication elsewhere unless specific permission is obtained from the Editors prior to submission.

Manuscripts will undergo a double-blind peer review process and an EJMINT Editor will make the final decision relative to publication.

EJMINT encourages and particularly supports investigations that are prospective in nature and in which specific hypotheses are proposed.

Unless otherwise agreed with the Editors, all authors must read the Author License to Publish Agreement and to download and sign a copy of the Acceptance Form available here.

Author Responsibilities

By submitting a manuscript for publication, each author acknowledges having made a substantial contribution to the concept and design of the study, the analysis and interpretation of the results and the writing of the paper. Importantly, submission implies that each author has approved the final submitted version and, therefore, acknowledges responsibility for the integrity of the manuscript, assures the originality of the paper and guarantees that duplicate or redundant publications/submissions have not occurred. Authors may indicate level of contribution to the paper and this will be reflected in the final published article. The Editors reserve the right to request the original data obtained in the investigation.

Conflicts of interest and/or disclosure statements (if applicable) must be completed during the electronic submission process. Each author must verify authorship and declare conflicts before the paper will be assigned to an editor so please be sure you have up to date email addresses for each author listed on the manuscript. Disclosure is not intended to prevent authors with potential conflicts of interest from contributing to EJMINT; rather, it places on record any relationship that may exist with mentioned or competing products or firms. Authors are responsible for notifying the Journal of financial arrangements including but not limited to agreements for research support (including provision of equipment or materials), speaker bureaus, consulting or ownership interests. It is important that disclosure statements be updated promptly to reflect any new relationships that arise after the initial submission of the manuscript.

When a large, multicentre group has conducted a study, the group should identify the individuals who accept direct responsibility for the manuscript. At least one person’s name must accompany a group name (e.g., Z. Kulcsar for MOON Investigators). When submitting a group author manuscript, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Other group members will be listed in the Acknowledgments. Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as "Clinical Investigators" and their function or contribution should be described (e.g., "served as scientific advisors," "collected data" or "provided and cared for study patients"). The National Library of Medicine indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript.

All authors should read the following instructions before submitting a manuscript to assure timely handling and review of their material. Authors should strive to present their manuscripts in a clear and logical manner. Authors are responsible for all statements made in the text.

We strongly encourage authors for whom English is not their native language to seek assistance from a colleague experienced in medical terminology and translation to ensure that the language accurately and clearly conveys the intended meaning. Failure to do so may compromise the review of your manuscript. Because understanding and correctly displaying non-English names can be complicated, we urge our authors to review the Title Page instructions below carefully.

These instructions are based in part on recommendations as set forth in the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals and the AMA Manual of Style. Authors are encouraged to consult both publications, which contain helpful details on the construction and writing of scientific manuscripts. Variations from guidelines in those publications reflect the individual style of EJMINT.

Ethical Statement

EJMINT is committed to protecting the rights of research participants and subjects and requires authors to adhere to the ethical principles outlined in the 1964 Declaration of Helsinki and later amendments (revised 2013). EJMINT also requires authors to affirm that Institutional Review Board/Ethics Approval Committee approval has been granted or waived for all research studies involving human and/or animal subjects. A patient consent statement is required for all submitted manuscripts and in the event experimental animals are included, authors must include a section in Methods to confirm that appropriate measures were taken to minimize pain or discomfort, including an outline of animal care. Finally, all manuscripts must include one of the following statements before the Conflict of Interest statement:

Ethical standards and consent

We declare that our study adheres to the ethical principles outlined in the 1964 Declaration of Helsinki and later amendments. We declare that this study has been approved by the [insert appropriate ethics committee] and all patients or their representatives gave informed consent prior to enrollment.

Animal Studies (if appropriate)

We declare that this study followed the Guide for the Care and Use of Laboratory Animals (the Guide, NRC 2011) as well as [insert specific country laws if applicable].

or

We declare that this manuscript does not contain clinical investigations or participant data.

Duplicate/Redundant Publication

Manuscripts submitted to EJMINT should conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”. Manuscripts submitted to EJMINT should not contain material previously published in other publications, except as an abstract, and must not be currently under consideration for publication in another journal. Characteristics of reports that are substantially similar include (a) "at least one of the authors must be common to all reports”; (b) "the subject or study populations are often the same or similar"; (c) "the methodology is typically identical or nearly so"; and (d) "the results and their interpretation generally vary little, if at all."

Manuscript Submission

EJMINT uses an electronic submission and review process to promote expeditious peer review. Manuscripts should be submitted electronically via the following website: www.editorialmanager.com/ejmint

Questions about manuscripts under consideration may be addressed to:

Managing Editor: managingeditor@ejmint.com

All authors listed on the manuscript must complete author verification and disclosure forms during the electronic manuscript submission process. As previously stated, submissions without verification or fully completed disclosure forms for each author will not progress to the editor or undergo peer review.

Initial Review Process

The Editors will initially evaluate submitted manuscripts. A rapid initial decision of whether to have a manuscript formally reviewed by two or more reviewers with appropriate expertise or rejected without a formal review will be determined by the senior editor and a second reviewer (Associate Editor, Section Editor, Editorial Board member or invited reviewer with topic-related expertise) based on the quality, originality, scientific rigor and data presentation/analysis of the manuscript. The Editor-in-Chief has full authority over the entire editorial content of EJMINT journal and the publication timing of said content.

Back to top

Article Types

Original Research

Word Limit: 4750 words including abstract
Abstract - 250 words

Text, including references and tables - 4500 words

  • NUMBER OF AUTHORS - 5-10 for retrospective studies; 10-15 for prospective studies.
  • TITLE PAGE - The following information should appear: title of article; first name, middle initial, and last name of author(s); affiliations, grant support, and presentation in part or whole at any meeting. Identify the corresponding author and provide full mailing address, telephone/FAX numbers and e-mail address. Authors must indicate exactly how they want their names to appear.
  • ABSTRACT - The abstract is limited to 250 words and should describe the essential aspects of the investigation in four subheadings: Introduction (in the first sentence state the background information/rationale for the investigation; Purpose; Methods; Results (summarise data); and Conclusion (brief statement directed to the stated purpose or hypothesis). No cited references.
  • ABBREVIATION KEY - Please list abbreviations used within the abstract, text, legends, and tables along with their definitions. Abbreviations will appear on the first page of the printed article and should not be expanded in other portions of the manuscript. The Abbreviation Key will not be factored into an article's word count. Authors are encouraged to limit the amount of abbreviations whenever possible to enhance the reader's experience.
  • INTRODUCTION - Please write a brief introduction to the paper that outlines the Background/Purpose in further detail.
  • METHODS - This section may be divided into subsections if it enhances readability. The research design, patients/subjects, material used, means of confirming diagnoses and statistical methods should be included. Papers with statistical analysis should be prepared in consultation or co-authorship with an individual whom has statistical expertise. Do not include results or discussion in this section. Do not include manufacturer’s names unless the specific product is important to the procedures performed; if the manufacturer’s name is included, list the city and state or country of the manufacturer. Indicate that informed consent has been obtained from patients who participated in clinical investigations. In animal experimentation, acknowledge that specific guidelines were followed. When appropriate, indicate that approval was obtained from the institution’s review board. If there is a sponsoring company, at the end of this section state what input that company had in the formulation of the paper.
  • RESULTS - This section may be divided into subsections if it enhances readability. Present results in a clear, orderly fashion, and include statistical findings to substantiate the results. All results based on methods must be included. If tables and graphic material will ease the understanding of the results, include them. However, when the results can be summarised easily in a narrative form, do not use tables. Cite figures to illustrate findings.
  • DISCUSSION - Start with limited, pertinent background information and then discuss the results of the investigation in light of what has been previously published, the limitations of your study, the implications for patient care and potential directions for future research. Where appropriate, cite figures and graphs.
  • CONCLUSION - In a separate section, summarise the major findings of the study and their clinical usefulness (if applicable). This paragraph should address the purpose stated earlier in the paper.
    
- ACKNOWLEDGMENTS - Obtaining permission to include a name in this section from the acknowledged individual is advised.
  • CONFLICT OF INTEREST - State whether a conflict of interest exists by incorporating one of the following statements: “EW (author initials) has a financial relationship with or consults for…” or “We declare that we have no conflict of interest”.
  • 
FIGURES - The average one-column image plus legend equals 100 words; space taken up by figures must be subtracted from the text word count.
  • REFERENCES - Provide only references that give essential background material. SEE ALSO: References

Technical Notes

Word Limit: 2150 including abstract
Abstract - 150 words
Text, including references and tables - 2000 words

While EJMINT encourages the submission of full-length Original Research papers, it will consider the publication of a limited number of concise Technical Notes. These should be unusually educational and medically important.

  • NUMBER OF AUTHORS - No more than 5.
  • TITLE PAGE - SEE: Original Research/Title Page

  • ABSTRACT - The abstract should be a 250-word summary of the article.
  • ABBREVIATION KEY - SEE: Original Research/Abbreviation Key.
  • INTRODUCTION - Describe the essence of the report.
  • TECHNIQUE - Describe the technique. Write in the past tense.
  • DISCUSSION - Highlight the educational value of the technique.
  • FIGURES - The average one-column image plus legend equals 100 words; space taken up by figures must be subtracted from the text word count.
  • REFERENCES - Provide only the references that give essential background materials. SEE ALSO: References.

Review Articles

Word Limit: 4750 including abstract
Abstract - 150 words
Text, including references and tables - 4600 words

PLEASE NOTE: The Editor-in-Chief solicits Review articles. Unsolicited review articles will not be considered for publication.

  • TITLE PAGE - SEE: Original Research/Title Page.
  • ABSTRACT - The abstract should be a one-paragraph summary of the article.
  • ABBREVIATION KEY - SEE: Original Research/Abbreviation Key.
  • TEXT - After a brief introduction, this section may be divided into subsections to facilitate reading the paper. Discuss pertinent background information, review the major findings of articles published in the past and the limitations of these studies, the implications for patient care and potential directions for future research.
  • ACKNOWLEDGMENTS - Obtaining permission to include a name in this section from the acknowledged individual is advised.
  • CONFLICT OF INTEREST - State whether a conflict of interest exists by incorporating one of the following statements: “EW (author initials) has a financial relationship with or consults for…” or “We declare that we have no conflict of interest”.
  • TABLES AND FIGURES - If tables and graphic material will ease the understanding of the results, include them. However, when the results can be summarised easily in a narrative form, do not use tables. Cite figures to illustrate findings. Five illustrations and one table are generally sufficient to supplement the text of a Review Article.
  • REFERENCES - Provide only the references that give essential background material. Review Articles generally contain an average of 65 references. SEE ALSO: References.

Editorials

Word limit: 1500 words
Abstract - 150 words
Text, including references and tables - 1350 words

Editorials are usually commissioned by the Editor and are subject to the double-blind review process. Authors wishing to submit an Editorial should seek the advice of the individual Editor prior to submission.

  • TITLE PAGE - SEE: Original Research/Title Page.
  • TABLES AND FIGURES - 1 table or figure.

  • ACKNOWLEDGMENTS - Obtaining permission to include a name in this section from the acknowledged individual is advised.
  • CONFLICT OF INTEREST - State whether a conflict of interest exists by incorporating one of the following statements: “EW (author initials) has a financial relationship with or consults for…” or “We declare that we have no conflict of interest”.
  • REFERENCES - Provide only the references that give essential background material. Editorials may contain no more than 25 references. SEE ALSO: References.

Letters to the Editor

Letters to the Editor may describe (in an extremely brief manner) an observation of interest to our readers, an opinion relative to the practice of minimally invasive interventional therapy or constructive observations or criticisms of published material. Letters should be no more than two pages (approximately 500 words) and should be submitted with a brief title (and a title page containing Corresponding Author contact information as outlined above) but no salutation. A maximum of 4 references may be included. Letters are published at the discretion of EJMINT and are subject to editing.

Back to top

General Information

Electronic Format Requirements

When possible, please submit all files in production-ready formats. We cannot publish your manuscript without receiving correctly formatted files.

Document Files

  • Submit an electronic version of the manuscript as a Microsoft Word (DOC or DOCX) or RTF file. Please note that Abstracts and Keywords should be included in your main document in addition to being posted in the space provided in the electronic submission system.
  • All text is to be paginated and double-spaced with sufficient margins.
  • Font: Times New Roman; font size at least 12 points.
  • DO NOT justify margins.
  • Preserve anonymity by ensuring that the authors’ names appear only on the title page (which should be a separate electronic file) and by eliminating references to institutions, affiliations, and previous work by the authors (stated as such in the manuscript) in any part of the paper, including the Acknowledgments or Conflict statement. The electronic file name should also be blinded/generic.
  • Organise the manuscript as follows: Title Page (separate file), blind Title Page (title only), Abstract, Keywords, Introduction, Methods, Results, Discussion, Conclusion, Acknowledgments, Conflict of interest, References, Tables and Figure Legends.
  • Keep acronyms to a minimum. When an abbreviation is used, define it in the Abbreviation Key. Authors are encouraged to limit the amount of abbreviations whenever possible to enhance the reader's experience.
  • For revisions, please include a blinded cover letter detailing all changes that were made to the manuscript but DO NOT include any author names or affiliations. You will be prompted for this letter by Editorial Manager upon submitting your revision.

Figures and Legends

  • EJMINT only uses electronic images. Submit all figures in JPG, TIF or EPS format.
  • Each image should be a separate file with the figure number indicated in the filename.
  • Legends should be in present tense (e.g., ‘DSA shows…’).
  • Images should not be redundant. Avoid excessive illustrative material.
  • Images should be uniform in size and magnification.
  • Sagittal projections or lateral images are to be submitted with the patient facing the reader’s left.
  • Illustrations should not have marks, circles or numbers in the area around the image and should be free of all identifying information relative to the patient and institution.
  • Line drawings should be professional in quality and in black on a white background.
  • Written permission for use of all previously published illustrations must be included with submission and the source should be referenced in the legends.
  • Written permission from any recognisable person in a photo is required.
  • Legends must be double-spaced, and figures and tables numbered in the order cited in the text.
  • Label all pertinent findings.
  • RESOLUTION REQUIREMENTS FOR JPG/TIF/EPS FILES:
    • Line Art (black and white) - 1200 DPI/PPI
    • Halftones - 300 DPI/PPI
    • Combination Halftones - 600 DPI/PPI
    • Images should be a minimum size of 4 inches wide at the stated resolution.

Color Charges

  • There are no color charges.

Electronic modification/manipulation of Image files

The following global changes to improve the quality of illustrations or remove identifying information are acceptable:

  • changing image size and resolution as detailed above
  • globally adjusting contrast and brightness (as long as no parts of an image are completely masked)
  • blocking or erasing patient/institutional/manufacturer identifiers
  • minimally "cleaning" unwanted noise in the background
  • aligning an image that is tilted
  • cropping unnecessary surrounding black space
  • All cloning, whether completed to delete or enhance a part/s of an image is viewed as suspicious. No specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Any manipulation of an image must be explained in the accompanying legend.

Tables

  • Each table is displayed without vertical or horizontal rules.
  • Prepare tables with word processing (e.g., Microsoft Word Table feature) or spreadsheet (e.g., Microsoft Excel) software. - Graphic files are not acceptable for tables.
  • Type size may be reduced to accommodate high numbers of columns (tables may span more than one page).
  • Each table has a short, descriptive title.
  • Tables are numbered in the order cited in the text.
  • Abbreviations are defined as footnotes at the bottom of each table.
  • Tables should not duplicate data given in the text or figures.
  • The “Results” section should refer the reader to the appropriate table.

References

The guidelines provided in this section are applicable to Original Research, Technical Notes and Review Articles. The AMA reference style should be used for any type of manuscript submission.

  • Section must be double-spaced.
  • References are numbered consecutively in the order in which they appear in the text. All references must be cited in the text in square brackets, (e.g. [1] or [3-5] or [6, 8-10] etc,).
  • Data such as abstracts from meetings should be cited in the reference list. For meeting abstracts, cite the authors, title, society meeting, date and location.
  • Citations of personal communications should appear in the “Discussion” section only and should not be used to support the authors’ conclusions.
  • Papers submitted but not yet accepted for publication should also be cited in the text (J. Byrne, unpublished data, 2011).
  • Inclusive page numbers (e.g., 333-37) must be provided for all references.
  • Journal names are abbreviated per Index Medicus.
  • All authors are listed; where there are five or more authors, only the first four may be listed followed by “, et al.”
  • The list of authors names must be separated by commas, should not contain commas and must be terminated with a semicolon.
  • The article/book title must be terminated by a semicolon
  • The year of publication should follow the Journal Name or Publisher, and be followed by a semicolon
  • Where an article has been published by a group, the group name should follow any author names at the start of the reference, (see example below).

Style and punctuation of references follow the format illustrated in the following examples:

Journal Article:

  1. Szikora I, Berentei Z, Kulcsar Z, Marosfoi M, et al.; Treatment of intracranialaneurysms by functional reconstruction of the parent artery: the Budapest experience with Pipeline embolization device; Am J of Neuroradiology 2010; 31(6):1139-47.
  2. Molyneux A, Kerr R, Stratton I, et al., International Subarachnoid Aneurysm Trial (ISAT) Colaborative Group; International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial; Lancet 2002; 360:1262-1263.

Book:

Byrne JV; Interventional Neuroradiology: Theory and Practice; Oxford University Press 2002; 1st edition

Chapter in an Edited Book:

Hudgins PA, Jacobs IN, Castillo M; MR of the neck; In: Som PM, Curtin HD, eds; Head and Neck Imaging 3rd ed.; St Louis: Mosby 1996; 545-611.

Multimedia Files

Any multimedia files to be published in the eJournal should be uploaded to Editorial Manager in QuickTime (MOV). Please do not send DivX Video (AVI) or Windows Media Clip (MPG) files.

Expedited Publication

The Editors invite submission of manuscripts that have major importance to the scientific community. To be considered for expedited publication, an article must be unique and contain information that could make a significant difference in medical practice or constitute an important advance in basic knowledge. The authors must clearly state reasons for the expedited request in the cover letter. If the Editors agree that an article should be an expedited publication, they will arrange an accelerated review and, if accepted, accelerated publication.